Evotec

logo-evotec-rgb-color
logo-evotec-rgb-color

Description

For over 30 years, Evotec has offered extensive drug discovery and development solutions, navigating your projects from target identification to the clinic.

We integrate deep disease understanding, a multimodality approach, advanced technologies, and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic pipeline-building partnerships, regardless of your stage in the discovery-development journey.

Evotec SE is a publicly listed company headquartered in Hamburg, Germany. Evotec's sites in Europe and the USA offer highly synergistic technologies and services and operate as complementary clusters of excellence.

Advanced Technologies

We provide high quality, AI/ML data-driven solutions, leveraging cutting-edge technologies such as our proprietary molecular patient database, iPSC technologies, PanOmics platform and our multiomics data analysis software, PanHunter, to enhance the accuracy and success rate of drug development

Therapeutic Area Expertise

Through extensive research and partnerships, we have gained deep understanding of the underlying biology, molecular mechanisms, and therapeutic targets in a wide range of disease areas, including oncology, CNS disorders, auto-immune conditions, infectious diseases, and metabolic disorders. Our collaborative approach fosters innovation and adaptability, enabling us to address drug discovery challenges across diverse therapeutic areas.

Modalities

Effectively treating certain diseases requires a multimodal strategy that leverages small molecules, biologics, antibody-drug conjugates, oligonucleotide therapies, different target classes, and cell therapies. Each approach offers distinct advantages by targeting different aspects of a disease’s biology. At Evotec we have pioneered advancements across these therapeutic modalities, supporting projects from initial concept through to the clinic.

By integrating these techniques, a multimodal approach creates a comprehensive treatment strategy that simultaneously targets multiple pathways and mechanisms of disease progression. This holistic approach not only maximizes therapeutic efficacy but also minimizes drug resistance and side effects, paving the way for truly personalized medicine

Our People

At Evotec, collaboration, expertise, and creativity drive successful drug discovery across all sites. We prioritize strong partnerships, proactive alliance management, and flexible, solution-driven thinking to develop impactful treatments. Our diverse team focuses on innovation and entrepreneurship, fostering enduring relationships that positively impact patients' lives through integrated solutions for complex diseases.

Capabilities:

  • Discover More
  1. Target ID & Validation
  2. Hit Identification
  3. Structural Biology
  4. Molecular Design & Medicinal Chemistry
  5. In Vitro Biology
  6. In Vivo Pharmacology
  7. Biomarkers
  8. Bio Reagents & Cellular Sciences
  9. Safety Assessment
  10. Sample Management
  11. Pharmacometrics
  • Transition Better
  1. Lead Optimization: Refine target product profile, assess developability, and strategize
    PDC nomination.
  2. Expert Engagement: Involve senior experts early for efficient PDC and IND/CTA pathways.
  3. Tailored Plans: Joint team crafts candidate nomination plans, led by development experts.
  4. Risk Mitigation: Comprehensive PDC nomination plan to address early-stage liabilities.
  5. Development Readiness: Ensure candidate readiness with pharmaceutical developability and safety activities.
  • Develop Faster
  1. Evotec INDiGO® - IND-enabling product
  2. API Process Development & Manufacturing
  3. API & Drug Product Commercial Manufacturing
  4. Analytical Development, Quality Control & Stability
  5. Material Science
  6. Early Formulation
  7. Drug Product Development & Manufacturing
  8. Safety Assessment
  9. Abuse Liability Assessment
  10. Bioanalysis
  11. Pharmacometrics
  12. Regulatory Support
  13. Clinical Development & Translational Medicine
Certification
United States FDA, GMP, ISO, Europe EMA

Capabilities

Contact Information

Website
Twitter (X)
Address
Essener Bogen 7, Manfred Eigen Campus, 22419, Hamburg, Germany
Zip/Post Code
22419

The PharmaSource Newsletter

Register today to our free email newsletter for the latest insights into BioPharma outsourcing.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.